drugset / Trial / NCT07670884
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to evaluate the efficacy and safety of HRS9531 tablets compared with placebo in reducing body weight in overweight or obese subjects after 52 weeks of treatment.
Timeline
- Start
- 2026-07
- Primary completion
- 2027-07
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS9531 | Unknown | — | — |
Indications
No indication recorded.